David McClung - 30 Jun 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
Chief Financial Officer
Signature
/s/ David McClung
Issuer symbol
BCDA
Transactions as of
30 Jun 2025
Transactions value $
$9,999
Form type
4
Filing time
02 Jul 2025, 21:03:36
Previous filing
25 Apr 2025
Next filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McClung David Chief Financial Officer C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE /s/ David McClung 02 Jul 2025 0001686155

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $10K +4.82K +11.17% $2.08 48K 30 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Warrant (right to buy) Purchase +4.82K +22.46% 26.3K 30 Jun 2025 Common Stock 4.82K $1.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.